The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors.-论文-万方医学网

作者： Tiantian,Liu ^[1] ; Taylor C,Brown ; C Christofer,Juhlin ; Adam,Andreasson ; Na,Wang ; Martin,Bäckdahl ; James M,Healy ; Manju L,Prasad ; Reju,Korah ; Tobias,Carling ; Dawei,Xu ; Catharina,Larsson

作者单位： Department of Medicine-Solna, Karolinska Institutet, Karolinska University Hospital CMM, SE-171 76 Stockholm, Sweden Yale Endocrine Neoplasia Laboratory, Yale School of Medicine, 333 Cedar Street, FMB130A, PO Box 208062, New Haven, Connecticut 06520, USA Department of Surgery, Yale School of Medicine, New Haven, Connecticut, USA Departments of Oncology-Pathology Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital CCK, SE-171 76 Stockholm, Sweden Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA. ^[1]

主题词青少年(Adolescent);肾上腺肿瘤(Adrenal Gland Neoplasms);肾上腺皮质腺瘤(Adrenocortical Adenoma);肾上腺皮质癌(Adrenocortical Carcinoma);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);病例对照研究(Case-Control Studies);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);男(雄)性(Male);中年人(Middle Aged);突变(Mutation);肿瘤复发, 局部(Neoplasm Recurrence, Local);肿瘤分期(Neoplasm Staging);副神经节瘤(Paraganglioma);嗜铬细胞瘤(Pheochromocytoma);预后(Prognosis);启动区, 遗传(Promoter Regions, Genetic);RNA, 信使(RNA, Messenger);逆转录聚合酶链反应(Reverse Transcriptase Polymerase Chain Reaction);存活率(Survival Rate);末端转移酶端粒(Telomerase);青年人(Young Adult)

DOI 10.1530/ERC-14-0016

PMID 24803525

发布时间 2021-10-21

检索历史清除

The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors.

Endocrine-related cancer

相似文献

Endocrine-related cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors.

Endocrine-related cancer

相似文献

Endocrine-related cancer

相关期刊

检索历史清除